15th Annual Biomarkers Congress
During the 15th Annual Biomarkers Congress (18-20 February 2020, Manchester, UK) our expert will present challenges and approaches in biomarker panel validation.
The use of biomarkers to quicken timelines and ensure clinical success in drug development will be a key topic discussed at the 15th Annual Biomarkers Congress. As the pharmaceutical industry focuses on achieving increasingly more efficient and successful drug development through informed decision making, meet our experts at Booth 32 to discuss how Intertek can support your biomarker assay development, validation and biomarker studies. Contact us to arrange a meeting during the event.
STREAM 3: Biomarkers for Preclinical to Clinical Development
Validation of a biomarker panel in different matrices – challenges and approaches
- Clinical biomarkers measuring the inflammatory response by immunoassay platforms
- Discussion on how endogenous levels across multiple clinical matrices impact the development process
- Evaluation of the approaches taken for fit-for-purpose validation
- Reflection on the context of use of biomarker assays
Joshua Pickering, Senior Analyst, Bioanalysis Services
Thursday, February 20, 12:20-12.50pm
Our Biomarker and Bioanalysis Expertise
Our biomarker services provide fit-for-purpose validations in support of exploratory biomarkers based on your product requirements and full validation for confirmatory biomarkers where clinical decisions are being made to understand the drug’s efficacy and safety profile. Intertek utilises a diverse array of analytical platforms to support biomarker analysis including ELISA, flow cytometry, cell-based assays and ECL multiplex platforms.
We also provide bioanalytical pharmacokinetic and immunogenicity analysis for pre-clinical and clinical studies. Our GMP and CMC support programs include biologic product characterization packages, method development and validation, impurities analysis, stability, batch release and cell based potency testing. We apply our experience and depth of industry knowledge to help you to navigate the challenges of new product development, scale-up, manufacturing, bioanalysis and market release to meet regulatory expectations
More About the 15th Annual Biomarkers Congress
From the 18th to 20th February 2020, over 350 delegates from pharmaceutical and biotech organisations, CROs and academia will meet in Manchester, UK, to discuss the latest developments in biomarker applications, methods, best practice and regulatory considerations.
Need help or have a question?